The Indianapolis-based pharmaceutical giant hopes to enroll up to 400 people in a study to see if its drug baricitinib can treat patients with severe cases of Covid-19.
Lilly Has Begun Phase 3 Clinical Trials To See If Its Rheumatoid Arthritis Drug Treats Covid-19
